Delaying reperfusion plus left ventricular unloading reduces infarct size: Sub-analysis of DTU-STEMI pilot study.

Heart assist devices Left ventricular unloading Myocardial infarction ST segment elevation

Journal

Cardiovascular revascularization medicine : including molecular interventions
ISSN: 1878-0938
Titre abrégé: Cardiovasc Revasc Med
Pays: United States
ID NLM: 101238551

Informations de publication

Date de publication:
09 Oct 2023
Historique:
received: 24 07 2023
revised: 11 09 2023
accepted: 22 09 2023
medline: 28 10 2023
pubmed: 28 10 2023
entrez: 27 10 2023
Statut: aheadofprint

Résumé

The STEMI-DTU pilot study tested the early safety and practical feasibility of left ventricular (LV) unloading with a trans-valvular pump before reperfusion. In the intent-to-treat cohort, no difference was observed for microvascular obstruction (MVO) or infarct size (IS) normalized to either the area at risk (AAR) at 3-5 days or total LV mass (TLVM) at 3-5 days We now report a per protocol analysis of the STEMI-DTU pilot study. In STEMI-DTU STUDY 50 adult patients (25 in each arm) with anterior STEMI [sum of precordial ST-segment elevation (ΣSTE) ≥4 mm] requiring primary percutaneous coronary intervention (PCI) were enrolled. Only patients who met all inclusion and exclusion criteria were included in this analysis. Cardiac magnetic resonance (CMR) imaging 3-5 days after PCI quantified IS/AAR and IS/TLVM and MVO. Group differences were assessed using Student's t-tests and linear regression (SAS Version-9.4). Of the 50 patients enrolled, 2 died before CMR imaging. Of the remaining 48 patients those without CMR at 3-5 days (n = 8), without PCI of a culprit left anterior descending artery lesion (n = 2), with OHCA (n = 1) and with ΣSTE < 4 mm (n = 5) were removed from this analysis leaving 32/50 (64 %) patients meeting all inclusion and exclusion criteria (U-IR, n = 15; U-DR, n = 17) as per protocol. Despite longer symptom-to-balloon times in the U-DR arm (228 ± 80 vs 174 ± 59 min, p < 0.01), IS/AAR was significantly lower with 30 min of delay to reperfusion in the presence of active LV unloading (47 ± 16 % vs 60 ± 15 %, p = 0.02) and remained lower irrespective of the magnitude of precordial ΣSTE. MVO was not significantly different between groups (1.5 ± 2.8 % vs 3.5 ± 4.8 %, p = 0.15). Among patients who received LV unloading within 180 min of symptom onset, IS/AAR was significantly lower in the U-DR group. In this per-protocol analysis of the STEMI-DTU pilot study we observed that LV unloading for 30 min before reperfusion significantly reduced IS/AAR compared to LV unloading and immediate reperfusion, whereas in the ITT cohort no difference was observed between groups. This observation supports the design of the STEMI-DTU pivotal trial and suggests that strict adherence to the study protocol can significantly influence the outcome.

Identifiants

pubmed: 37891053
pii: S1553-8389(23)00829-1
doi: 10.1016/j.carrev.2023.09.009
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest NKK, JEU, WWO, GWS receive consulting/speaking honoraria from Abiomed. MP, AK, RHK, JWM, NA and HF have no relevant disclosures.

Auteurs

Navin K Kapur (NK)

Tuft University Medical Center, Boston, MA, United States of America. Electronic address: nkapur@tuftsmedicalcenter.org.

Mohit Pahuja (M)

University of Oklahoma Medical Science, Oklahoma city, OK, United States of America.

Ajar Kochar (A)

Brigham and Women's Hospital, Boston, MA, United States of America.

Richard H Karas (RH)

Tuft University Medical Center, Boston, MA, United States of America.

James E Udelson (JE)

Tuft University Medical Center, Boston, MA, United States of America.

Jeffrey W Moses (JW)

Columbia University Medical Center, New York, United States of America.

Gregg W Stone (GW)

Hackensack Medical Center, Hoboken, NJ, United States of America.

Nima Aghili (N)

St. Anthony's Hospital, Denver, Colorado, USA.

Haroon Faraz (H)

Hackensack Medical Center, Hoboken, NJ, United States of America.

William W O'Neill (WW)

Henry Ford Hospital, Detroit, MI, United States of America.

Classifications MeSH